Abstract
The prevalence of allergic diseases has increased worldwide during the past two decades. Change of dietary habit is thought to be one of the environmental factors, which has caused such an increase and worsened allergic symptoms, which suggests that an appropriate dietary habit may substantially prevent the onset of allergic diseases and ameliorate allergic symptoms. Flavonoids, which are polyphenolic plant secondary metabolites ubiquitously present in vegetables, fruits and beverages, possess antioxidant and anti-allergic activities as well as immune-modulating traits. Flavonoids inhibit the activation of mast cells and basophils and therefore suppress the release of chemical mediators, synthesis of Th2 type cytokines such as interleukin (IL)-4 and IL-13, and CD40 ligand expression, They also reportedly inhibit IL-4-induced signal transduction and affect the differentiation process of naïve CD4+ T cells into effector T cell subsets. A cohort epidemiological study in Finland found a significantly low incidence of asthma in a population with a high intake of flavonoids. Moreover, various studies of flavonoids in allergic models such as asthma, atopic dermatitis, anaphylaxis and food allergy demonstrated their beneficial effects, while experience in humans is at the moment limited to respiratory allergy. Although further validation is required, it is anticipated that an appropriate intake of flavonoids may play a role in the prevention and eventually in the management of allergic diseases.
Keywords: Allergic rhinitis, allergy, asthma, complementary and alternative medicine, dietary treatment, flavonoid, prevention.
Current Pharmaceutical Design
Title:Flavonoids for Allergic Diseases: Present Evidence and Future Perspective
Volume: 20 Issue: 6
Author(s): Toshio Tanaka
Affiliation:
Keywords: Allergic rhinitis, allergy, asthma, complementary and alternative medicine, dietary treatment, flavonoid, prevention.
Abstract: The prevalence of allergic diseases has increased worldwide during the past two decades. Change of dietary habit is thought to be one of the environmental factors, which has caused such an increase and worsened allergic symptoms, which suggests that an appropriate dietary habit may substantially prevent the onset of allergic diseases and ameliorate allergic symptoms. Flavonoids, which are polyphenolic plant secondary metabolites ubiquitously present in vegetables, fruits and beverages, possess antioxidant and anti-allergic activities as well as immune-modulating traits. Flavonoids inhibit the activation of mast cells and basophils and therefore suppress the release of chemical mediators, synthesis of Th2 type cytokines such as interleukin (IL)-4 and IL-13, and CD40 ligand expression, They also reportedly inhibit IL-4-induced signal transduction and affect the differentiation process of naïve CD4+ T cells into effector T cell subsets. A cohort epidemiological study in Finland found a significantly low incidence of asthma in a population with a high intake of flavonoids. Moreover, various studies of flavonoids in allergic models such as asthma, atopic dermatitis, anaphylaxis and food allergy demonstrated their beneficial effects, while experience in humans is at the moment limited to respiratory allergy. Although further validation is required, it is anticipated that an appropriate intake of flavonoids may play a role in the prevention and eventually in the management of allergic diseases.
Export Options
About this article
Cite this article as:
Tanaka Toshio, Flavonoids for Allergic Diseases: Present Evidence and Future Perspective, Current Pharmaceutical Design 2014; 20 (6) . https://dx.doi.org/10.2174/13816128113199990060
DOI https://dx.doi.org/10.2174/13816128113199990060 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
Blood-based biomarkers in large-scale screening for neurodegenerative diseases
Disease biomarkers are necessary tools that can be employ in several clinical context of use (COU), ranging from the (early) diagnosis, prognosis, prediction, to monitor of disease state and/or drug efficacy. Regarding neurodegenerative diseases, in particular Alzheimer’s disease (AD), a battery of well-validated biomarkers are available, such as cerebrospinal fluid ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Diabetes mellitus: advances in diagnosis and treatment driving by precision medicine
Diabetes mellitus (DM) is a chronic degenerative metabolic disease with ever increasing prevalence worldwide which is now an epidemic disease affecting 500 million people worldwide. Insufficient insulin secretion from pancreatic β cells unable to maintain blood glucose homeostasis is the main feature of this disease. Multifactorial and complex nature of ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Review for Lithium: Pharmacokinetics, Drug Design, and Toxicity
CNS & Neurological Disorders - Drug Targets Dietary Patterns in Alzheimers Disease and Cognitive Aging
Current Alzheimer Research Anti-Tumor Necrosis Factor-Alpha (TNF-α) Treatment Strategies in Crohns Disease
Recent Patents on Inflammation & Allergy Drug Discovery The Ryanodine Receptor: A Pivotal Ca2+ Regulatory Protein and Potential Therapeutic Drug Target
Current Drug Targets Honey as a Source of Dietary Antioxidants: Structures, Bioavailability and Evidence of Protective Effects Against Human Chronic Diseases
Current Medicinal Chemistry Autophagy as a Molecular Target of Flavonoids Underlying their Protective Effects in Human Disease
Current Medicinal Chemistry Foods and Drugs in the Management of Disease: A Case Study Comparing Omega-3 Fatty Acids and Aspirin for Inflammation
Current Pediatric Reviews Relative Expression of Mouse Udp-glucuronosyl Transferase 2b1 Gene in the Livers, Kidneys, and Hearts: The Influence of Nonsteroidal Anti-inflammatory Drug Treatment
Current Drug Metabolism Emerging Anticoagulant Therapies for Atrial Fibrillation: New Options, New Challenges
Current Medicinal Chemistry Proteome and Metabolome Alterations in Heart and Liver Indicate Compromised Energy Production During Sepsis
Protein & Peptide Letters Colorectal Cancer Microenvironment: Among Nutrition, Gut Microbiota, Inflammation and Epigenetics
Current Pharmaceutical Design Prevention and Treatment of Alzheimer Disease and Aging: Antioxidants
Mini-Reviews in Medicinal Chemistry CTLA-4Ig: Uses and Future Directions
Recent Patents on Inflammation & Allergy Drug Discovery Investigation on the Detection of a Brain Disease by the Use of the Active Contour Methods
Current Medical Imaging Mycobacterial DNA GyrB Inhibitors: Ligand Based Pharmacophore Modelling and In Vitro Enzyme Inhibition Studies
Current Topics in Medicinal Chemistry Reversible Complete Heart Block in a Pregnant Woman Responding to Steroids: A rare Case Report
New Emirates Medical Journal Sundowning Syndrome: A Possible Marker of Frailty in Alzheimer’s Disease?
CNS & Neurological Disorders - Drug Targets Fatty Acid (FA) Compositions and Trans Content of Frequently Consumed Edible Oils and Fats from Iran’ Market
Current Nutrition & Food Science Propitious Profile of Peppery Piperine
Current Molecular Pharmacology Regulation of Apolipoprotein B by Natural Products and Nutraceuticals: A Comprehensive Review
Current Medicinal Chemistry